You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雪榕生物(300511.SZ):擬與中科中山共建“中科中山藥物創新研究院雪榕多糖聯合實驗室”
格隆匯 01-05 21:20

格隆匯1月5日丨雪榕生物(300511.SZ)公佈,2022年1月5日,公司與中科中山藥物創新研究院(“中科中山”)簽署了《關於建設“中科中山藥物創新研究院雪榕多糖聯合實驗室”的協議書》,雙方決定共建“中科中山藥物創新研究院雪榕多糖聯合實驗室”,進行基於繡球菌等多糖創新藥物研究。

本次與中科中山共建“聯合實驗室”,重點進行繡球菌等多糖活性機制及食用菌提取物的研究,食用菌提取物包括β-1,3葡聚糖等,聚焦食藥用菌提取物在升白抗腫瘤(提升白細胞,激活免疫細胞)、提升免疫力、抗氧化、抗病毒等方面的研究,公司將藉助中科中山強大的研發實力,通過定期開展學術及技術等方面的交流活動,迅速提升公司在食藥用菌提取物的研發能力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account